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Background: There is growing evidence that preconception care may have an important role in preventing short
and long term adverse health consequences for women and their offspring. This is particularly the case for women
with chronic health conditions due to the rising prevalence of chronic disease in global populations. With this in
mind, this paper presents an integrative systematic review of contemporary research outlining the use of
preconception services and practices by women with chronic health conditions.
Methods: A search was conducted through PubMed, CINAHL, AMED, and Maternity and Infant Care databases
which identified 672 papers examining preconception care and preconception services for women with chronic
health conditions. Fourteen papers which were written in English, presented original research, and reported on the
prevalence or nature of use of preconception care by women with chronic health conditions were included in the
review. Critical appraisal of study quality and thematic categorical grouping of identified papers was undertaken.
Results: Current research evidence, as identified through this review, examines three major topic areas: the
prevalence of preconception care practices, use of services and characteristics of users; knowledge of the value and
impact of preconception care and availability of preconception services for women with chronic health conditions;
and women’s attitudes, approaches and experiences of preconception care and preconception services. Prevalence
estimates of engagement with preconception care range between 18.1% and 45%, with most studies focusing on
women with type 1 or 2 diabetes. Significant gaps in women’s knowledge of preconception care for women with
chronic health conditions were also identified. Women with chronic health conditions reported experiencing
emotional distress as a result of their engagement with preconception care services. They also commonly described
feeling a need to employ discipline to comply with preconception care programs, and experiencing a fear of
pregnancy complications.
Conclusion: Future research requires a broad and sophisticated approach to research design and analysis,
improved consideration of temporal changes to women’s health behaviour, representative samples to more
effectively inform health policy, and a deeper understanding of women’s motivations, attitudes and perceptions of
preconception care to assist in the development of tailored preconception health services.
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Preconception care is an approach to health promotion
and preventive medicine which focuses on interventions
that identify and modify biomedical, behavioural and
social risks to a woman’s health or pregnancy outcome
[1]. By its nature, preconception care relates to care
before pregnancy, whether it be a first pregnancy or be-
tween consecutive pregnancies, and the importance of
this component of contemporary health care has been
acknowledged by a range of international bodies and or-
ganisations representing health professionals and policy
makers [2-5].
Impact of preconception health status on outcomes for
women and neonates
Preconception care has received increased attention due
to growing evidence that maternal health prior to con-
ception can directly affect the health of the mother and
the fetal environment during pregnancy [2]. The major-
ity of research attention over the last 20 years has been
directed to the benefits of folic acid supplementation in
preventing birth defects [6-10]. The broader field of pre-
conception care research emphasises the impact of the
fetal environment on adverse outcomes such as miscar-
riage [11], stillbirth [12], congenital disorders [13], and
macrosomia [14]. Fetal environment has also been found
to impact on risk of the development of chronic diseases
such as obesity [15], diabetes and cardiovascular disease
[16], and cancer [17] through epigenetic and other cellu-
lar responses to developmental exposures [18]. Maternal
health behaviours which have been clearly identified as
important in the context of preconception care include
diet [19], smoking [20], alcohol consumption [21] and
exposure to communicable diseases [22].
In light of these developments, and the higher preva-
lence of important risk behaviours in sub-groups includ-
ing women with lower socio-economic status [21,23]
and teenagers [24], attempts have been made to inform
women of childbearing age and modify preconception
health behaviours through the development of health
policy and guidelines alongside the implementation of
preconception care programs within the community
[25-29].
Importance of preconception care for women with
chronic health conditions
Chronic and non-communicable diseases are the largest
cause of death in the world and as such have a well-
established global epidemiological and economic impact
[30]. In addition, the prevalence of the most common
chronic diseases is growing, particularly in developing
countries, and is projected to continue to increase [30].
This has led to calls for key stakeholders, including pub-
lic health researchers, to direct more research towardschronic disease and its impact [30]. In line with this, the
clinical impact of preconception care for women with
chronic health conditions has received focused attention
from researchers. Diabetes has received particular atten-
tion because the preconception health of women with
either type 1 or type 2 diabetes has been found to impact
on the risk of congenital malformations, preterm deliv-
ery and perinatal mortality of their offspring [31]. Pre-
pregnancy maternal obesity is linked to an increased
likelihood of preterm birth and low birth weight [32] as
is hypertension [33], depression [34] and autoimmune
disease [35]. Whilst some research has reported no ad-
verse effects from non-immune hypothyroidism in the
preconception period if appropriately managed through
antepartum care [36], untreated thyroid dysfunction is
also linked with an increased risk of obstetric and neo-
natal complications [37]. In contrast, the risk of adverse
pregnancy outcomes for women with epilepsy is directly
associated with the antiepileptic drugs used as part of
treatment [38].
Some commentators and policymakers have attempted
to inform the development of preconception programs
to improve prenatal health status and reduce the inci-
dence of adverse outcomes in offspring of women with
chronic health conditions [39-41]. Preconception pro-
grammes and interventions have been developed and
implemented for women of childbearing age with
chronic health conditions with varying degrees of suc-
cess [31,42-45]. A recent systematic review and meta-
analysis examining the impact of preconception care for
preventing and managing chronic disease confirmed the
value in preconception interventions [45]. In particular,
the review concluded a reduced incidence of congenital
malformations for preconception care of women with
diabetes as well as highlighting the importance of pre-
conception management of epilepsy [45].
Effective intervention programmes requires not only
knowledge of the effectiveness of the intervention but
also insights into the knowledge, attitudes, and health
behaviours of the target populations. It is also important
that those responsible for preconception programmes and
interventions have an understanding of the characteristics
which influence women’s likelihood to engage with pre-
conception services or undertake health preconception
practices. Insights beyond effectiveness outcomes such as
these have the capacity to enhance preconception service
delivery by ensuring it is tailored and responsive to the
needs of the community. In answer, this paper provides a
review of international contemporary literature with a spe-
cific focus upon the prevalence and nature of use of pre-
conception care practices and services by women with
chronic health conditions. By focusing on these factors
this review offers an important supplement to efficacy and
effectiveness research and will be able to inform future




A database search was conducted to identify peer-
reviewed literature published between 2003 and October
2014 examining the use of preconception care practices
and services by women with a chronic health condition.
Literature published before 2003 were not included as
previous research examining women’s attitudes and
knowledge towards preconception care has identified
rapid changes to the women’s understanding of precon-
ception care over time [46]. Based upon this, manu-
scripts more than 10 years old would hold limited value
to future work. The search was conducted in November
2014 and included PubMed, CINAHL, AMED, and
Maternity and Infant Care. The search terms included:
preconception care or prenatal care; thyroid diseases;
diabetes mellitus; cardiovascular diseases; depressive
disorder; obesity; allergy; immunology; and chronic
disease. Manual searching of the reference lists of identi-
fied papers was also conducted to ensure no relevant pa-
pers had been overlooked. Papers were included if they
were written in English, presented original research, and
reported on the prevalence or nature of use of preconcep-
tion care. Manuscripts were excluded if they presented re-
sults from experimental research designs, or only reported
on the impact of preconception care on pregnancy or
birth outcomes.
Search outcome
The search results (n = 672) were imported into Endnote
referencing and bibliography management software. A
total of 93 papers were excluded as duplicates and an
additional 556 papers were identified as not complying
with the inclusion criteria based upon their title or ab-
stract. Upon reviewing the full text articles, 5 articles
were excluded due to their focus on the general popula-
tion rather than women with a chronic health condition
and 4 other papers were excluded as they reported an
experimental design. The process undertaken for this re-
view is presented in Figure 1.
Analysis of included papers
Critical appraisal and analysis
The critical appraisal of study quality for research exam-
ining clinical outcomes was conducted by applying a
quality scoring system, modified from a system previ-
ously developed and applied [47,48]. This system was
designed to systematically compare and evaluate the
studies reviewed and allow for appraisal across three di-
mensions: methodology; reporting of participants’ char-
acteristics; and preconception care services examined.Methodology was appraised according to the use of a
representative sampling strategy, adequate sample size, a
response or participation rate of >75%, and low retro-
spective measurement error (defined as prospective data
collection or retrospective data collection within the
previous 12 months) [47]. Quantitative papers were
appraised according to a determination of sample size
based upon a power analysis of >80%. Where the power
analysis was not reported a sample of >385 was accepted
based upon standard precision analysis principles to
account for possible sampling error [49]. Qualitative
papers were appraised according to whether they re-
ported achieving thematic saturation during data collec-
tion [50]. Appraisal of sample size for qualitative studies
was based upon a minimum sample of 15 participants
where thematic saturation was not reported. Finally, the
studies were assessed for the examination of preconcep-
tion care services. Studies were critiqued based upon their
examination of comprehensive preconception clinical care
services – here defined as services where multiple compo-
nents of preconception care are delivered [51] - rather
than uptake of a stand-alone health behaviour, as well as
preconception care-related health promotion and patient
education. The three dimensions which form the quality
assessment tool were selected for inclusion in the critical
framework in line with the aim of this review. Each com-
ponent of the three dimensions was awarded 1 point if the
paper achieved the minimum defined requirement and
cumulative scores for each paper were calculated with a
maximum potential score of 11. Scores for the studies
were assigned independently by two authors. The results
were then compared and differences resolved by discus-
sion. A study receiving a quality score of >8 was deter-
mined to be of acceptable quality as it reflects significant
representation across at least 2 of the 3 domains of inter-
est: methodology, reporting of participant characteristics,
and preconception services examined.
Categorical grouping of the identified papers was also
undertaken by the first author through an inductive
process grounded in the content of the papers. This itera-
tive process involved reading and re-reading the papers,
extracting relevant information, and identifying common
themes within the reported findings. Upon developing the
categories, the included studies were examined again and
assigned to a relevant category. Individual studies were
assigned to as many categories as appropriate based upon
the content of the paper.
Results
An overview of all papers included in the review includ-
ing preliminary categorical analysis is outlined in Table 1.
The review papers identified 14 studies conducted in
North America [52-57], the United Kingdom [58-61],
Australia [62,63], France [64], and Malta [65]. The studies
Figure 1 The literature search and selection process (figure uploaded separately).
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[53,56-61,63,65,66] published since 2010. The research
designs varied between the studies with both quantita-
tive [52,55-57,61,63-65] and qualitative [53,54,58-60,62]
methodologies reported. The quantitative studies utilised
a number of survey design approaches and drew on sam-
ple sizes between 27 [65] and 6385 [52]. The qualitative
studies employed primarily semi-structured interviews in-
volving between 7 [62] and 29 [60] women, although one
study used focus groups conducted with a total of 72
women [53]. All of the identified papers examined women
with type 1 diabetes [52-66], however women with type 2
diabetes [52,53,56-58,60,61,63], hypertension [53,57] and
overweight/obesity [52,53] were also explored in some
studies.
The quality score of each relevant individual study is re-
ported in Table 2. The quality appraisal of included papers
identified only 4 papers with a score of 8 [52,53,55,61].
Many studies did not report sufficient detail on the re-
sponse or participation rate [52-54,56-65] and the major-
ity did not report the time since participant’s diagnosis of
the chronic health condition [52-54,57,61-63,65] but be-
yond this the quality issues were inconsistent across stud-
ies. Only two studies did not address any of the criteria for
methodological quality [62,64].
Through analysis of the findings reported in each of
the identified studies, three descriptive categories of
results was developed: prevalence of preconception care
practices, use of preconception services and characteristicsof users; knowledge of the value and impact of preconcep-
tion care and availability of preconception services; and at-
titudes, approaches and experiences of preconception care
and preconception services.
Prevalence of preconception care practices, use of
preconception services, and characteristics of users
Prevalence of engagement with preconception care ser-
vices and practices, and the characteristics of women
who undertook to use preconception care was examined
in 5 of the reviewed papers [52,55,56,61,63]. The preva-
lence estimates ranged between 18.1% through to 45%
depending upon the health condition being examined
[52,56,61,63]. Primarily, the studies reporting the preva-
lence of preconception care use explored the engagement
with preconception care counselling services provided
through community health clinics with a specific focus on
women with type 1 or type 2 diabetes [56,61,63]. One
large US population study (n = 6385) examined folic acid
supplementation for women who had diagnosed diabetes
or were classified as overweight or obese and found 35%
of total respondents self-administered folic acid [52].
A Canadian study of women attending a health clinic
(n = 464) found a notable difference in preconception
care service use between women with type 1 (43.1%)
and type 2 (18.4%) diabetes [56], a trend which was
also reported in a similar UK study (n = 588) [61].
Within the subgroup of women with type 1 diabetes,
those who: are younger; have lower weight; have
Table 1 Summary of identified papers examining preconception care in women with chronic health conditions with thematic categorical groupings
Author (Year) Country Method Data source/Participant recruitment Target population Conditions examined Sample Theme
I II III
Case et al. [52] United States Cross-sectional survey Texas 1999–2003 Behavioural Risk Factor
Surveillance System
Non-pregnant women Obesity, overweight,
diabetes
6385 X





France Cross-sectional survey Patients (outpatients and hospitalised)
from specialist diabetes centres (n = 11)
Non-pregnant women Type 1 diabetes 138 X
Griffiths et al. [54] United Kingdom Semi-structured interviews UK specialist diabetes antenatal clinics
(n = 4)
Pregnant women Type 1 diabetes 15 X X
Kallas-Koeman et al. [56] Canada Prospective observation
and survey
Electronic medical records from diabetes
clinic
Non-pregnant women Type 1 and Type 2
diabetes
464 X
Kim et al. [55] United States Prospective survey Translating Research into Action for
Diabetes (TRIAD) cohort study
Non-pregnant women Type 1 diabetes 302 X
King and Wellard [62] Australia Collective case study
(via in-depth interviews)




Type 1 diabetes 7 X
Lavender et al. [58] England Semi-structured interviews
and focus groups
Obstetric and diabetes clinics in hospitals
in North-West England (n = 3)
Women with previous
pregnancy
Type 1 and Type 2
diabetes
22 X
McCorry et al. [59] Ireland Semi-structured interviews Non-pregnant women Type 1 diabetes 14 X
Mittal et al. [57] United States Cross-sectional survey San Francisco General Hospital Family
Health Center registry
Non-pregnant women Diabetes, hypertension,
obesity
27 X X
Murphy et al. [60] England Semi-structured interviews Diabetes specialist antenatal clinics
(n = 3)
Women who did not attend
preconception care
Type 1 or Type 2
diabetes
29 X
Sapiano et al. [65] Malta Longitudinal survey Diabetes hospital outpatient clinic Non-pregnant women Type 1 diabetes 27 X
Tripathi et al. [61] England Cross-sectional survey Northern Diabetes in Pregnancy Survey Women with previous
pregnancy
Type 1 or Type 2
diabetes
588 X
Zhu et al. [63] Australia Prospective survey Diabetes hospital outpatient clinic Non-pregnant women Type 1 or Type 2
diabetes
51 X X
I: Prevalence of engagement with preconception services and characteristics of users.
II: Women’s knowledge of preconception care benefits, preconception information sources, and availability of preconception services.
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treatment, are more likely to report preconception
care practices such as focusing on glucose control or
family planning counselling [55].
Women’s knowledge of preconception care benefits,
preconception information sources and availability of
services
This category overviews the findings from the included
studies as it relates specifically to participants knowledge
of the benefits of appropriate preconception care be-
haviours such as avoiding tobacco and alcohol use,
undertaking regular exercise, or supplementing with
folate. Women’s awareness of available preconception
services and sources of information regarding precon-
ception health are also included in this category. The
examination of women’s knowledge of preconception
care and availability of preconception services for women
with a chronic health condition has been disparate and in-
dividual studies have explored the topic from different an-
gles. However, significant gaps in women’s knowledge
have been consistently identified across the six studies
[53,54,57,63-65] examining this topic. Such gaps include a
limited knowledge of the pregnancy risks associated with
chronic medical conditions whether as a general risk
[53,57,65], or associated with specific adverse outcomes
[64]. A study involving focus groups of non-pregnant
women with diabetes, hypertension or obesity also found
that participants’ knowledge of behaviours which optimise
preconception health and the impact of chronic health
conditions on contraceptive choices was limited [53].
More than half (60%) of women who attended a hospital
for antenatal services with diabetes were found to have no
knowledge of the availability of a preconception service at
the hospital.
A cross-sectional survey (n = 138) of women with type
1 diabetes investigating the factors that influence the
women’s level of knowledge regarding pregnancy risk
and preconception care found participants were better
informed if they had a younger age of onset of the health
condition, were multiparous, had a higher level of edu-
cation, or monitored their blood glucose more than
three times each day [64]. Sources of information related
to pregnancy risk and preconception care needs for
women with a chronic health condition were also ex-
plored. The majority of women (85%) had received in-
formation about pregnancy from a health professional
or through leaflets, although 14% had received notifi-
cation after a previous unplanned pregnancy and
therefore were unable to engage with preconception
services for that pregnancy [64]. This finding was also
confirmed through a study drawing on semi-structured
interviews of pregnant women with type 1 diabetes
who sought advice from their usual health professionalearly in pregnancy with information only occasionally
provided to them preconception [54]. Another smaller
survey of women with type 1 diabetes (n = 27) comple-
ments the findings of the larger study but reported pre-
ferred rather than actual information sources. This
smaller study indicated women with type 1 diabetes
preferred their doctor or specialist as a source of infor-
mation (81%) followed by books or leaflets (51%) the
internet (46%) and diabetes clinic staff (46%). Standard
media was the least preferred (30%) [65].
Women’s attitudes and experiences of preconception care
and preconception services
This category specifically relates to women’s attitudes
towards the concept of using preconception services or
the experiences of those who have used preconception
services in the past and includes 6 identified studies
[54,57-60,62]. Women reported experiencing emotional
stress whilst attempting to comply with preconception
requirements unique to their diagnosed health condition
and avoid pregnancy complications [58,59,62,63], and
needing discipline to follow the guidelines outlined by
health professionals to minimise their pregnancy risk
[62]. Others reported that women’s experience of pre-
conception counselling contributed to fear of pregnancy
complications to such a level that it made the decision
to conceive more difficult [54]. Within the studies ex-
ploring women’s attitude and experience of preconcep-
tion care, a trend towards fear and resistance to the
present approach to preconception counselling including
a perceived medicalisation of the condition [54,58,59]
and a preference for more holism in the approach to
preconception care [59] is evident.
Aside from these concerns, the decision to conceive is
reportedly associated with a change in health behaviour,
even for those women who were not always strict with
their diet and lifestyle [62] which has been attributed to
a desire to be as healthy as possible to ensure the best
outcomes for the baby. However, this change is not al-
ways able to be maintained by the woman and can result
in a haphazard approach to preconception care [58].
Barriers to women’s ability to engage with, or maintain,
preconception practices not only include the emotional
concerns highlighted above, but also employment type,
particularly as they relate to the ability to implement
and maintain diet and lifestyle change [62]. In addition,
women have also identified the need to share private in-
formation, regarding their intentions to conceive, with
employers to enable flexibility for medical appointments
during work hours [58] and the perceived time needed
for attending appointments [63]. This impact of time for
appointments may also be exacerbated for those living
in rural areas by the geographical distance to preconcep-
tion service providers [63].
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This review provides an examination of the prevalence
and nature of the use of preconception care services by
women with chronic health conditions worldwide. The
significance of this work is underpinned by the inter-
national commitment to both preconception care and
the management of chronic health in a population
health context. Clear policy statements describing the
significance and consequence of preconception care
have been developed by international organisations
and governing bodies [2-5]. A key element in these
policies has been the importance of attenuating the se-
verity of chronic health conditions prior to pregnancy
to minimise the risk of obstetric and postnatal health
problems. In line with this, a growing trend of research
examining the use of preconception care practices by
women with chronic health conditions is highlighted
by this review, with 10 out of 14 studies published
since 2010. As is common with the emerging nature of
this research topic, there is inconsistency in some of
the work conducted and limited scope in other areas.
There are a number of gaps in available knowledge to
inform those committed to translating the current
policies and guidelines into meaningful and effective
preconception programmes and services. One such gap
is due to a limited approach to data collection and ana-
lysis which does not give adequate consideration to the
needs of women with differing chronic health condi-
tions, or the breadth and diversity of chronic health
conditions which may benefit from preconception
health services. Similarly, the scope of health behav-
iours and health services used by women with chronic
health conditions for preconception care has been rela-
tively narrow. Another knowledge gap in this field is
due to a focus on retrospective cross-sectional studies
with little examination of women’s change in use of
health services prior to attempting to conceive, whilst
actively planning conception, and into the antenatal
period. Finally, very little of the existing research has
examined the motivations, perceptions and attitudes
towards preconception care and preferences for pre-
conception services of women with chronic health
conditions. Without dedicating future research atten-
tion to these areas, the development of preconception
services and programs which are sensitive to the health
behaviours and needs of the women they are targeting
will be limited. As such, a possible agenda for future
research to address these gaps, whilst not exhaustive, is
proposed. Due to the breadth of research still needed
in this field, the following agenda prioritises: sophistication
in data analysis; longitudinal studies and improved repre-
sentativeness; and attention to understanding the motiva-
tions, perceptions and attitudes of preconception care
stakeholders.A broad and sophisticated approach to research design
and analysis
There is value in broadening the range of chronic health
conditions examined in the context of preconception
care beyond the current dominant focus on type 1 dia-
betes. Given the known health implications of maternal
type 2 diabetes [31], obesity [32], hypertension [33],
depression [34], autoimmune disease [35] and thyroid
disorders [37] for both mother and offspring, these
additional conditions also require close attention. In
fact, in light of the growing rates of obesity in both de-
veloped [67,68] and transitional [69,70] economies and
the increasing awareness of the importance of address-
ing depression in contemporary maternity care [71] it
could be argued that these two conditions need a pri-
ority focus in future research.
The development of knowledge in this topic area would
also benefit from a differential approach to women’s con-
ception intentions within research design and analysis.
Current research indicates that women who are actively
trying to conceive, those trying to avoid pregnancy, and
those that are ambivalent differ in a range of characteris-
tics such as age, parity, importance of motherhood, self-
identifying a fertility problem, relationship satisfaction and
economic hardship [72]. It may be beneficial to examine
these groups of women separately and in contrast to one
another given the potential differences in their preferences
and needs from a preconception service, their ability to
commit to preconception care planning or changes, and
the goals which motivate them to make health behaviour
changes. By taking this approach, researchers will be
better positioned to provide meaningful findings to
health professionals and policy makers which can in-
form the provision of tailored and relevant preconcep-
tion care for all women of childbearing age with chronic
health conditions.
Beyond a specific and discrete focus on women with
chronic health conditions, there is also a need to expand
the research scope to include other stakeholders such as
women’s partners and health care providers. Given the
impact a woman’s partner can have on women’s intention
to conceive [72], and potentially on their engagement with
preconception care [73], examination of the partners of
women with a chronic health condition in the context of
preconception care may provide valuable insights to assist
in the development of policies and programmes. Likewise,
the findings identified through this literature review sug-
gest the current approach of health professionals provid-
ing preconception care is perceived as more medicalised
and less holistic than would be preferred by women en-
gaging with these professionals. Future research needs to
more closely examine the interactions between health pro-
fessionals and women with chronic health conditions
undertaking preconception care to clarify this perception
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women in a manner which will encourage confidence
and lasting health behaviour change.
A final avenue which would add breadth to our under-
standing of the preconception care patterns of women
with chronic health conditions is the study of practices
and behaviours women undertake as part of their pre-
conception care. Current research examining health
behaviours during the preconception period focus on
smoking [20], alcohol use [21], diet [19] and exposure
to communicable disease [22]. This work needs to be
expanded to include focus upon general health service
use such as visits with primary care practitioners in-
cluding general practitioners and family physicians,
but also specific health service use such as specialist
doctors and complementary and alternative medicine
(CAM) providers. In fact, given the high rates of CAM
use reported for individuals with chronic health condi-
tions [74,75], and the similarly high rates identified in
women receiving fertility treatments [76], the use of
CAM during the preconception period and for precon-
ception care by women with chronic health conditions
would benefit from focused attention.
Improved consideration of temporal changes and sample
representativeness
Current health services research which examines pre-
conception care for women with chronic health condi-
tions, with one exception [52], draws upon samples
which are not generalisable due to the small sample
sizes [53,57,58,63,65] and non-representative sampling
methods [54-56,58-60,62-65]. As such the majority of
work in this area has limited external validity. There is
a clear need to explore this topic using nationally-
representative samples to provide more robust insights
into the prevalence of preconception health behaviours
and patterns of preconception service use by women
with chronic health conditions. A nationally-representative
study design will enhance the external validity of any
data in relationship to a target population of the country
it is intended to represent [77]. In order for this re-
search approach to best contribute to the current know-
ledge associated with the use of preconception care by
women with chronic health conditions, it is important
that such data includes a broad range of chronic health
conditions reflective of the range of pre-pregnancy con-
ditions linked with adverse birth outcomes, health be-
haviours, health service utilisation and attitudes towards
health and health care. It would be most cost effective
where possible to use existing data sources for this ana-
lysis (e.g. the Australian Longitudinal Study on Women’s
Health linked to administrative data from the Medicare
Benefits Schedule [78] for additional information on ac-
cess to services).Longitudinal data will also be a valuable component of
future research as it allows for the examination of
changes in behaviour throughout the childbearing years
[79]. Drawing upon longitudinal data would enable re-
searchers to explore differences in individual health
behaviours, health service use, and attitudes towards
health and health care during various life stages including
long term preconception, immediate preconception, ante-
natal, postnatal and interconception periods. The use of
longitudinal data would allow for not only comparisons
across defined life stages but also changes for individual
women over time. Within the context of chronic health
conditions this level of analysis would identify the degree
to which women with chronic health conditions change
their behaviour once planning to conceive and also the de-
gree to which these changes in behaviour continue on
through pregnancy.
The contribution of exploring motivations, attitudes
and perceptions to understanding preconception
practices
Complementing the above proposed research activities
with a comprehensive examination of the motivations,
attitudes and perceptions informing preconception
health behaviour is vital. It is only through understanding
these intrinsic characteristics of women with chronic
health conditions that preconception programmes and
services can be developed which respond adequately to
women’s needs. Qualitative research designs are best
placed to afford the necessary insights into this important
aspect of preconception research. The approach of quali-
tative methodology is interpretive, pragmatic, grounded in
the lived experiences of individuals, and commonly occurs
in natural (rather than constructed) settings [80]. Applica-
tion of research designs incorporating qualitative methods
would enable an exploration of women’s perceived prefer-
ences and needs regarding preconception care service
delivery including availability and access. This needs to be
considered in the context of the current findings of emo-
tional stress and fear but also the desire for holism within
the preconception care services encountered by women
with chronic health conditions identified within this re-
view [54,58,59].
The use of qualitative methodology will also enable a
closer examination of the motivations which may in-
form women using or not using preconception services,
or modifying health behaviour in the preconception
period – particularly for those intending to conceive.
Similarly, it would provide an important opportunity to
explore the perception and understanding of men re-
garding their role as male partners during the precon-
ception care process for women with chronic health
conditions, and likewise capture the experience and atti-
tude of health professionals.
Steel et al. BMC Women's Health  (2015) 15:14 Page 10 of 12Strength and limitations of this review
This review provides the first synthesis of health service re-
search studies examining preconception care use by women
with chronic health conditions. It highlights the limited evi-
dence base currently available to guide policy and practice
development. Most importantly it sets out a research
agenda to expand the evidence base to enable better models
of preconception care to be developed that respond to the
needs of women with a range of chronic diseases.
This review has a number of limitations due to the
heterogeneity of the studies restricting the ability to
comprehensively compare findings across studies or
interpret a consistent trend in results. Likewise, the
dominance of small sample sizes utilised to provide the
data reported in the studies restricts the capacity to infer
implications from the findings beyond the study settings
being examined. There was an over-representation of
studies investigating type 1 diabetes in preference to
other chronic health conditions and, as highlighted by
one of the identified studies [56], the results from the re-
search of type 1 diabetes may not represent the patterns
and experiences of women with other chronic conditions.
Similarly, the lack of differentiation between those intend-
ing to conceive and those who conceived accidently may
confuse the results of the identified studies. Despite these
limitations, this review provides the first overview of
health services research associated with the topic globally
and offers key insights for those providing care to women
with chronic health conditions as well as offering a clear
direction for the focus of future research on this topic.
Conclusions
Preconception care for women with chronic health
conditions is clearly a topic of increasing interest for
researchers and of increasing importance for health
care providers and policy makers. The health services
research in this field is still emerging and even as the
current evidence provides insights into the prevalence
and knowledge of preconception care, attitudes towards
preconception services and practices, and the characteris-
tics of users for this subset of the population there remain
significant research gaps requiring address. A framework
for future research requires more sophisticated study
design and methodology, the inclusion of more repre-
sentative study populations, the analysis of longitudinal
data, and dedicated attention to the attitudes, motiva-
tions and experiences of key stakeholders. By taking this
more expansive and focused approach to the examin-
ation of preconception care for women with chronic
health conditions, future research will be better placed
to inform health professionals, health services managers
and policy makers in the development of relevant and
meaningful preconception care programs and services
for women with chronic conditions.Competing interests
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